Home
Scholarly Works
Phase II study of bortezomib in advanced or...
Conference

Phase II study of bortezomib in advanced or metastatic urothelial cancer. A trial of the princess margaret hospital [PMH] phase II consortium.

Authors

Sridhar SS; Stadler W; Le L; Hedley D; Pond G; Wright J; Vokes E; Thomas S; Moore M

Volume

23

Pagination

pp. 422S-422S

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

June 1, 2005

Name of conference

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

Orlando, FL

Conference start date

May 13, 2005

Conference end date

May 17, 2005

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team